Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Alopecia | Research article

Association between male pattern baldness and testicular germ cell tumor: a meta-analysis

Authors: Jiatong Zhou, Shuai Xia, Tao Li, Ranlu Liu

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

The relationship between male pattern baldness and incidence of testicular cancer remains inconclusive. Hence, we performed the present meta-analysis based on all eligible case–control studies.

Methods

A comprehensive literature search was performed in July 30th 2018 based on PUBMED, EMBASE and Web of science database. Pooled odds ratio(OR) and its 95% confidence intervals (95% CIs) was calculated with a DerSimonian and Laird random-effects.

Results

The pooled results were included in this meta-analysis. Overall, We have demonstrated statistically signification between baldness(any pattern) and testicular cancer was identified (OR: 0.61, 95% CI:0.50–0.74). There was no obvious heterogeneity across included studies (P = 0.22 for heterogeneity, I2 = 30%). When subgroup analysis by types of baldness, We found a statistically significant association was observed that baldness(I-VII) might become a protective factor for the risk of testicular germ cell tumor(TGCT). There was no definite connection between alopecia and the different types of TGCT.

Conclusion

Individuals with any pattern baldness may have a decreased risk of testicular cancer, all of analyses studies are warranted to confirm our preliminary findings. According to subgroup analysis of different hair loss grades, we found that 2 stage(II) hair loss can decrease more strongly testicular cancer risk than any other grades. Despite of our findings, We still need further researches to advance knowledge in this field.
Literature
1.
go back to reference Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4(22):1.CrossRef Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4(22):1.CrossRef
2.
go back to reference Gormley GJ, et al. The effect of finasteride in men with benign prostatic hyperplasia. The finasteride study group. J Urol. 1992;167(2):1102–7. Gormley GJ, et al. The effect of finasteride in men with benign prostatic hyperplasia. The finasteride study group. J Urol. 1992;167(2):1102–7.
3.
go back to reference Kanti V, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Dtsch Dermatol Ges. 2011;9(s6):S1–S57. Kanti V, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Dtsch Dermatol Ges. 2011;9(s6):S1–S57.
4.
go back to reference Yassa M, et al. Male pattern baldness and the risk of prostate cancer. Ann Oncol. 2011;22(8):1824–7.CrossRef Yassa M, et al. Male pattern baldness and the risk of prostate cancer. Ann Oncol. 2011;22(8):1824–7.CrossRef
5.
go back to reference Mehta A, et al. Testosterone levels do not decline with age in healthy men. Open J Urol. 2013;03(4):173–8.CrossRef Mehta A, et al. Testosterone levels do not decline with age in healthy men. Open J Urol. 2013;03(4):173–8.CrossRef
6.
go back to reference Heilmann-Heimbach S, et al. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nat Commun. 2017;8:14694.CrossRef Heilmann-Heimbach S, et al. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nat Commun. 2017;8:14694.CrossRef
7.
go back to reference Mcglynn KA. Environmental and host factors in testicular germ cell tumors. Cancer Investig. 2001;19(8):842–53.CrossRef Mcglynn KA. Environmental and host factors in testicular germ cell tumors. Cancer Investig. 2001;19(8):842–53.CrossRef
8.
go back to reference Mirmirani P. Age-related hair changes in men: mechanisms and management of alopecia and graying. Maturitas. 2015;80(1):58–62.CrossRef Mirmirani P. Age-related hair changes in men: mechanisms and management of alopecia and graying. Maturitas. 2015;80(1):58–62.CrossRef
9.
go back to reference Liang W, et al. Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis. BMC Cancer. 2018;18(1):279.CrossRef Liang W, et al. Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis. BMC Cancer. 2018;18(1):279.CrossRef
10.
go back to reference Ji HL, et al. Cancer risk by the subtype of alopecia. Sci Rep. 2018;8(1):9748.CrossRef Ji HL, et al. Cancer risk by the subtype of alopecia. Sci Rep. 2018;8(1):9748.CrossRef
11.
go back to reference Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRef Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRef
12.
go back to reference Bax L, et al. More than numbers: the power of graphs in meta-analysis. Am J Epidemiol. 2008;169(2):249–55.CrossRef Bax L, et al. More than numbers: the power of graphs in meta-analysis. Am J Epidemiol. 2008;169(2):249–55.CrossRef
13.
go back to reference Seagroatt V, Stratton I. Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. Br Med J. 1997;316(7129):469–71. Seagroatt V, Stratton I. Bias in meta-analysis detected by a simple, graphical test. Test had 10% false positive rate. Br Med J. 1997;316(7129):469–71.
14.
go back to reference Petridou E, et al. Baldness and other correlates of sex hormones in relation to testicular cancer. Int J Cancer. 1997;71(6):982–5.CrossRef Petridou E, et al. Baldness and other correlates of sex hormones in relation to testicular cancer. Int J Cancer. 1997;71(6):982–5.CrossRef
15.
go back to reference Walcott FL, et al. A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr Cancer. 2002;44(1):44–51.CrossRef Walcott FL, et al. A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr Cancer. 2002;44(1):44–51.CrossRef
16.
go back to reference Trabert B, et al. Baldness, acne and testicular germ cell tumours. Int J Androl. 2011;34(4pt2):e59–67.CrossRef Trabert B, et al. Baldness, acne and testicular germ cell tumours. Int J Androl. 2011;34(4pt2):e59–67.CrossRef
17.
go back to reference Moirano G, et al. Baldness and testicular cancer: the EPSAM case-control study. Andrology. 2016;4(2):251–6.CrossRef Moirano G, et al. Baldness and testicular cancer: the EPSAM case-control study. Andrology. 2016;4(2):251–6.CrossRef
18.
go back to reference Zhou CK, et al. Relationship between male pattern baldness and the risk of aggressive prostate Cancer: an analysis of the prostate, lung, colorectal, and ovarian Cancer screening trial. J Urol. 2015;194(4):990–1. Zhou CK, et al. Relationship between male pattern baldness and the risk of aggressive prostate Cancer: an analysis of the prostate, lung, colorectal, and ovarian Cancer screening trial. J Urol. 2015;194(4):990–1.
19.
go back to reference Ross RK, et al. Serum testosterone in healthy black and white men. J Natl Cancer Inst. 1986;76(1):45–8.PubMed Ross RK, et al. Serum testosterone in healthy black and white men. J Natl Cancer Inst. 1986;76(1):45–8.PubMed
20.
go back to reference Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst. 1983;132(5):1151–5. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst. 1983;132(5):1151–5.
21.
go back to reference Palanisamy T. Minoxidil to treat androgenetic alopecia in men and women: what is it & how does it work? Am J Med Med Sci. 2014;4(6):262–5. Palanisamy T. Minoxidil to treat androgenetic alopecia in men and women: what is it & how does it work? Am J Med Med Sci. 2014;4(6):262–5.
22.
go back to reference Richiardi L, et al. Feasibility of recruiting a birth cohort through the internet: the experience of the NINFEA cohort. Eur J Epidemiol. 2007;22(12):831–7.CrossRef Richiardi L, et al. Feasibility of recruiting a birth cohort through the internet: the experience of the NINFEA cohort. Eur J Epidemiol. 2007;22(12):831–7.CrossRef
23.
go back to reference Inui S, Itami S. Molecular basis of androgenetic alopecia: from androgen to paracrine mediators through dermal papilla. J Dermatol Sci. 2011;61(1):1–6.CrossRef Inui S, Itami S. Molecular basis of androgenetic alopecia: from androgen to paracrine mediators through dermal papilla. J Dermatol Sci. 2011;61(1):1–6.CrossRef
24.
go back to reference Ingles SA, Liu SV, Pinski J. LHRH and LHR genotypes and prostate cancer incidence and survival. Int J Mol Epidemiol Genet. 2013;4(4):228–3.PubMedPubMedCentral Ingles SA, Liu SV, Pinski J. LHRH and LHR genotypes and prostate cancer incidence and survival. Int J Mol Epidemiol Genet. 2013;4(4):228–3.PubMedPubMedCentral
Metadata
Title
Association between male pattern baldness and testicular germ cell tumor: a meta-analysis
Authors
Jiatong Zhou
Shuai Xia
Tao Li
Ranlu Liu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-5197-5

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine